News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,286 Results
Type
Article (14871)
Company Profile (299)
Press Release (266110)
Multimedia
Podcasts (77)
Webinars (11)
Section
Business (79827)
Career Advice (161)
Deals (13335)
Drug Delivery (39)
Drug Development (50697)
Employer Resources (31)
FDA (5833)
Job Trends (5166)
News (145068)
Policy (10072)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (19)
Adcomms (14)
Allergies (80)
Alliances (21763)
ALS (124)
Alzheimer's disease (1026)
Antibody-drug conjugate (ADC) (239)
Approvals (6026)
Artificial intelligence (255)
Autoimmune disease (108)
Automation (9)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (99)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (340)
Cancer (3087)
Cardiovascular disease (235)
Career advice (147)
Career pathing (7)
CAR-T (215)
CDC (5)
Cell therapy (555)
Cervical cancer (14)
Clinical research (43612)
Collaboration (1132)
Company closure (2)
Compensation (577)
Complete response letters (37)
COVID-19 (1098)
CRISPR (86)
C-suite (534)
Cystic fibrosis (111)
Data (4271)
Denatured (14)
Depression (90)
Diabetes (253)
Diagnostics (1376)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (185)
Drug pricing (47)
Drug shortages (3)
Duchenne muscular dystrophy (211)
Earnings (31616)
Editorial (24)
Employer branding (4)
Employer resources (29)
Events (51581)
Executive appointments (620)
FDA (7556)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (972)
Gene editing (179)
Generative AI (20)
Gene therapy (480)
GLP-1 (502)
Government (1144)
Grass and pollen (3)
Guidances (165)
Healthcare (6610)
HIV (17)
Huntington's disease (42)
IgA nephropathy (74)
Immunology and inflammation (185)
Immuno-oncology (37)
Indications (61)
Infectious disease (1202)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (164)
Interviews (18)
IPO (7338)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (38)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1400)
Liver cancer (40)
Longevity (11)
Lung cancer (417)
Lymphoma (244)
Machine learning (24)
Management (7)
Manufacturing (372)
MASH (129)
Medical device (2671)
Medtech (2679)
Mergers & acquisitions (6607)
Metabolic disorders (718)
Multiple sclerosis (99)
NASH (13)
Neurodegenerative disease (226)
Neuropsychiatric disorders (68)
Neuroscience (1932)
Neurotech (1)
NextGen: Class of 2026 (2033)
Non-profit (865)
Now hiring (29)
Obesity (325)
Opinion (125)
Ovarian cancer (129)
Pain (99)
Pancreatic cancer (158)
Parkinson's disease (230)
Partnered (12)
Patents (298)
Patient recruitment (316)
Peanut (43)
People (26623)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase I (15448)
Phase II (20261)
Phase III (12810)
Pipeline (3129)
Policy (88)
Postmarket research (854)
Preclinical (6535)
Press Release (30)
Prostate cancer (143)
Psychedelics (49)
Radiopharmaceuticals (237)
Rare diseases (628)
Real estate (1447)
Recruiting (12)
Regulatory (9857)
Reports (19)
Research institute (970)
Resumes & cover letters (18)
Rett syndrome (23)
RNA editing (20)
RSV (16)
Schizophrenia (121)
Series A (180)
Series B (135)
Service/supplier (1)
Sickle cell disease (76)
Special edition (18)
Spinal muscular atrophy (118)
Sponsored (15)
Startups (2005)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (329)
Venture capital (67)
Weight loss (171)
Women's health (24)
Worklife (2)
Date
Today (17)
Last 7 days (276)
Last 30 days (1309)
Last 365 days (17828)
2026 (1325)
2025 (18111)
2024 (20547)
2023 (22416)
2022 (26825)
2021 (27807)
2020 (23360)
2019 (16229)
2018 (11741)
2017 (13747)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7487)
2012 (7532)
2011 (7614)
2010 (7429)
Location
Africa (154)
Alabama (64)
Alaska (2)
Arizona (70)
Arkansas (5)
Asia (18235)
Australia (3106)
California (7011)
Canada (1820)
China (761)
Colorado (243)
Connecticut (247)
Delaware (231)
Europe (39108)
Florida (887)
Georgia (207)
Hawaii (2)
Idaho (17)
Illinois (392)
India (34)
Indiana (158)
Iowa (8)
Japan (217)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (732)
Massachusetts (5522)
Michigan (108)
Minnesota (245)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1629)
New Mexico (13)
New York (1740)
North Carolina (818)
North Dakota (6)
Northern California (3430)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1265)
Puerto Rico (9)
Rhode Island (25)
South America (213)
South Carolina (9)
Southern California (2780)
Tennessee (39)
Texas (899)
United States (23094)
Utah (96)
Virginia (135)
Washington D.C. (37)
Washington State (584)
West Virginia (1)
Wisconsin (43)
281,286 Results for "adagio therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adagio Medical Reports Third Quarter 2025 Results
November 12, 2025
·
7 min read
Press Releases
Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities
October 16, 2025
·
5 min read
Press Releases
Adagio Medical Reports Second Quarter 2025 Results
August 13, 2025
·
6 min read
Press Releases
Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia
October 2, 2025
·
4 min read
Press Releases
Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium
September 18, 2025
·
4 min read
Press Releases
Adagio Medical Reports First Quarter 2025 Results
May 15, 2025
·
6 min read
Press Releases
Adagio Medical Provides Clinical and Business Updates
March 18, 2025
·
5 min read
Press Releases
Adagio Medical Reports Fourth Quarter and Full Year 2024 Results
March 31, 2025
·
6 min read
Press Releases
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
April 17, 2025
·
5 min read
Biotech Beach
Adagio Medical Announces First European Commercial Procedures and Commencement of U.S. FDA Pivotal IDE for Ventricular Tachycardia Cryoablation System
Adagio Medical, Inc. (“Adagio Medical”, “Adagio” or the “Company”) today announced the completion of the first commercial procedures using its recently CE-Marked VT Cryoablation System and the U.S. Food and Drug Administration (“FDA”) approval of the FULCRUM-VT Pivotal IDE study of the VT Cryoablation System.
May 16, 2024
·
12 min read
1 of 28,129
Next
